Using bibliometrics to measures firm knowledge: An analysis of the US pharmaceutical industry

Technology Analysis and Strategic Management

Volumn 12, Issue 4, 2000, Pages 465-476

  McMillan, G Steven ^a   Hamilton, Robert D ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHARMACEUTICAL INDUSTRY;

UNITED STATES;

EID: 0034493783     PISSN: 09537325     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537320020004168     Document Type: Article

References (25)

1. Theory and Research in Strategic Management: Swings in a Pendulum
2. Knowledge and the Firm: Overview
3. Patent Statistics as Eeconomic Indicators
4. Patents as Indicators of Corporate Technological Strength
5. Knowledge, Strategy, and the Theory of the Firm
6. Generic Knowledge Strategies in the US Pharmaceutical Industry
7. Innovative Productivity and Returns to Scale in the Pharmaceutical Industry
8. Appropriating the Returns from Industrial Research and Development
9. A Bibliometric Analysis of Pharmaceutical Research
10. Patents as Indicators of Corporate Technological Strength
11. Bibliometric Analysis of U.S. Pharmaceutical Industry Research Performance
12. PMA Statistical Fact Book
13. Direct Validation of Citation Counts as Indicators of Industrially Important Patents
14. Determinants of Technology Cycle Time
15. Absorptive Capacity: A New Perspective on Learning and Innovation
16. The Increasing Linkage Between US Technology and Public Science
17. An Analysis of the Critical Role of Public Science in Innovation: The Case of Biotechnology
18. Rivalry, Strategic Groups and Firm Profitability
19. Creating University-industry Alliances: An Organizational Learning Perspective